TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities
Journal of Proteome Research · 2025
DOI: 10.1021/acs.jproteome.5c00805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Shiyuan Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Genetics, Genomics and Bioinformatics Graduate Program, University of California, Riverside, California 92521-0403, United States. Hauptthemen laut MEDLINE: Vemurafenib, Melanoma, Drug Resistance, Neoplasm, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genetics, Genomics and Bioinformatics Graduate Program, University of California, Riverside, California 92521-0403, United States.
- Environmental Toxicology Graduate Program, University of California, Riverside, California 92521-0403, United States.
- Department of Chemistry, University of California, Riverside, California 92521-0403, United States.
ORCID-Profile: Yinsheng Wang
Förderung
- NIEHS NIH HHS
- National Institute of Environmental Health Sciences
Zitieren
APA
Guo, S., Qi, T., & Wang, Y. (2025). TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00805
Vancouver
Guo S, Qi T, Wang Y. TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00805
BibTeX
@article{Guo2025,
author = {Guo, Shiyuan and Qi, Tianyu and Wang, Yinsheng},
title = {TRMU Confers Resistance of Melanoma Cells to Vemurafenib through Modulating Mitochondrial Activities},
journal = {Journal of Proteome Research},
year = {2025},
doi = {10.1021/acs.jproteome.5c00805}
}
EUVIMED